[Treatment of psoas haematoma in a patient with haemophilia and inhibitors].
BACKGROUND
Particular problem in treating haemophiliacs with serious muscle bleeding such as iliopsoas haematoma, are patients with inhibitor.


METHODS
Our study describes three episodes of psoas haematoma in a patient with haemophilia and inhibitor successfully treated with recombinant activated factor VII (rFVIIa).


CONCLUSIONS
Based on our experience, initiating therapy within two hours in our patient, contributed to successful treatment, although small cumulative doses of rFVIIa were used. Therefore, introducing home treatment along with adequate patient and family education similar to developed countries becomes imperative in our environment, not only for providing better quality of life, but also from pharamaco-economic point of view.
Janić
Dragana
D
Dokmanović
Lidija
L
Krstovski
Nada
N
Rodić
Predrag
P
Lazić
Jelena
J
Smoljanić
Zeljko
Z
D000293:Adolescent; D015942:Factor VIIa / Q000627:therapeutic use*; D005296:Ferrous Compounds / Q000627:therapeutic use*; D006406:Hematoma / Q000150:complications / Q000188:drug therapy*; D006467:Hemophilia A / Q000150:complications*; D006801:Humans; D008297:Male; D016658:Psoas Muscles; D011994:Recombinant Proteins / Q000627:therapeutic use
D005296:Ferrous Compounds; D011994:Recombinant Proteins; C014580:hemostimulin; C103587:recombinant FVIIa; D015942:Factor VIIa